Recombinant Anti-ANTXR1 Neutralizing Antibody (V3S-0622-YC25) (CAT#: V3S-0622-YC25)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with ANTXR1. The ANTXR1 antibody was effective at slowing tumor growth in the UACC melanoma model. A combination of the mAb and paclitaxel is effective against H460 cancer cells in the xenograft model, and that the combination is more effective than either agent alone.
Clonality Monoclonal
Host Species Human
Target Species Human, Mouse
Affinity 3.744 nM for mouse and 1.57 nM for human
Isotype IgG1

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application FuncS
Application Notes The antibody is recommended for detection of ANTXR1 by FuncS assay.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target ANTXR1
Alternative Name ATR; GAPO; TEM8; anthrax toxin receptor 1; 2310008J16Rik; 2810405N18Rik; tumor endothelial marker 8
Gene ID 84168
UniProt Q9H6X2
Research Area Microbiology
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry